EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Sex differences in the vasoactive effect of transient receptor potential channels: TRPM3 as a new therapeutic target for (neuro)vascular disorders

Eduardo Rivera-Mancilla iD, Usha M Musterd-Bhaggoe, Dennis Schutter, Antoon van den Bogaerdt, Arnaud J P E Vincent, Carlos M Villalón iD, Alexander H J Danser iD, Antoinette MaassenVanDenBrink iD

British Journal of Pharmacology · 2025

DOI: 10.1111/bph.17472 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Pharmacology, 2025. Verfasst von Eduardo Rivera-Mancilla und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Vascular Medicine and Pharmacology, Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands. Hauptthemen laut MEDLINE: TRPM Cation Channels, Sex Characteristics, Coronary Vessels, Transient Receptor Potential Channels. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Consejo Nacional de Ciencia y Tecnología, Secretaría de Educación, Ciencia, Tecnología e Innovación del Gobierno de la Ciudad de México, Nederlandse Organisatie voor Wetenschappelijk Onderzoek.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Purpose Sex‐dependent vascular effects of transient receptor potential (TRP) channels and sex dimorphism in migraine are not yet fully characterized. We investigated the differential vasoactive effects of TRP ankyrin 1 (TRPA1), TRP melastatin 3 (TRPM3) and TRP vanilloid 1 (TRPV1) channels, their pharmacological mechanism(s), and localization and expression in human isolated blood vessels. Experimental Approach Agonist responses to cinnamaldehyde (TRPA1), pregnenolone sulfate (PregS, TRPM3) or capsaicin (TRPV1) were analysed using wire myography in segments of human coronary (HCAs) and middle meningeal (HMMAs) arteries from men and women. The mechanisms involved in these responses were investigated using the antagonists/blockers/inhibitors: HC‐030031 (TRPA1), isosakuranetin (TRPM3), capsazepine (TRPV1), olcegepant (calcitonin gene‐related peptide [CGRP] receptor), L‐NAME (nitric oxide synthase [NOS]), indomethacin (cyclooxygenase [COX]), TRAM‐34 + apamin (K + channels) or MK‐801 ( N ‐methyl‐ d ‐aspartate [NMDA] receptor). Fluorescence microscopy, quantitative polymerase chain reaction (qPCR), and western blotting were performed to investigate their location and expression, respectively. Key Results In HCAs and HMMAs, (i) capsaicin‐induced relaxation remained unchanged after the above‐mentioned antagonists/blockers/inhibitors and (ii) cinnamaldehyde‐induced relaxation was blocked by olcegepant. PregS‐induced maximal relaxation was significantly enhanced in isolated arteries from females compared with males and was inhibited after isosakuranetin, MK‐801 or L‐NAME. TRPM3 mRNA and protein expression, along with NMDA protein levels, were higher in arteries from females than males. Conclusion and Implications Modulation of vascular tone in HCAs and HMMAs by activation of TRPM3 is sex‐dependent, likely involving NMDA receptors. This represents a new therapeutic direction, targeting sex dimorphism in migraine and its related cardiovascular events.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TRPM Cation ChannelsSex CharacteristicsCoronary VesselsTransient Receptor Potential ChannelsMaleFemaleHumansAdultMeningeal ArteriesAcroleinMiddle AgedTRPV Cation ChannelsMigraine Disorders

Stichwörter der Autor:innen

CGRPNMDA receptorsTRP channelsmigrainesex differencesvascular tone

Substanzen

TRPM Cation ChannelsTRPM3 protein, humanTransient Receptor Potential ChannelsAcroleincinnamaldehydeTRPV Cation Channels

Autor:innen und Institutionen

  • Division of Vascular Medicine and Pharmacology, Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Heart Valve Department, ETB-BISLIFE, Beverwijk, The Netherlands.
  • Department of Neurosurgery, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Department of Pharmacobiology, Cinvestav-Coapa, Mexico City, Mexico.

ORCID-Profile: Eduardo Rivera-Mancilla, Carlos M Villalón, Alexander H J Danser, Antoinette MaassenVanDenBrink

Förderung

  • Consejo Nacional de Ciencia y Tecnología
  • Secretaría de Educación, Ciencia, Tecnología e Innovación del Gobierno de la Ciudad de México
  • Nederlandse Organisatie voor Wetenschappelijk Onderzoek

Zitieren

APA

Rivera-Mancilla, E., Musterd-Bhaggoe, U. M., Schutter, D., van den Bogaerdt, A., Vincent, A. J. P. E., Villalón, C. M., Danser, A. H. J., & MaassenVanDenBrink, A. (2025). Sex differences in the vasoactive effect of transient receptor potential channels: TRPM3 as a new therapeutic target for (neuro)vascular disorders. British Journal of Pharmacology. https://doi.org/10.1111/bph.17472

Vancouver

Rivera-Mancilla E, Musterd-Bhaggoe UM, Schutter D, van den Bogaerdt A, Vincent AJPE, Villalón CM, et al. Sex differences in the vasoactive effect of transient receptor potential channels: TRPM3 as a new therapeutic target for (neuro)vascular disorders. British Journal of Pharmacology. 2025. doi:10.1111/bph.17472

BibTeX
@article{RiveraMancilla2025,
  author = {Rivera-Mancilla, Eduardo and Musterd-Bhaggoe, Usha M and Schutter, Dennis and van den Bogaerdt, Antoon and Vincent, Arnaud J P E and Villalón, Carlos M and Danser, Alexander H J and MaassenVanDenBrink, Antoinette},
  title = {Sex differences in the vasoactive effect of transient receptor potential channels: TRPM3 as a new therapeutic target for (neuro)vascular disorders},
  journal = {British Journal of Pharmacology},
  year = {2025},
  doi = {10.1111/bph.17472}
}
Kostenlos starten →